Skip to main content
SHPH
NASDAQ Life Sciences

Shuttle Pharmaceuticals Completes 1-for-10 Reverse Stock Split

Arie Shkolnikov · Analysis by Wiseek AI
More coverage: Pharmaceutical Stocks · Healthcare
Sentiment info
Negative
Importance info
7
Price
$4.18
Mkt Cap
0
52W Low
$3.81
52W High
$61.925
52W Position info
9.7% above low
Off High info
93% below high
Rel. Volume info
0.9× avg
Market data snapshot near publication time

SHPH is trading near its 52-week low of $3.81 (9.7% above the low).

Summary

Shuttle Pharmaceuticals completed a 1-for-10 reverse stock split, effective June 11, 2026, to adjust its share price and maintain Nasdaq listing compliance.


Key Events · Corporate Governance and Compliance · SHPH

  • Reverse Stock Split Executed

    The company filed a certificate of amendment to its charter, formally implementing a 1-for-10 reverse stock split.

  • Effective Date

    The reverse stock split became effective at the start of trading on June 11, 2026.

  • Impact on Convertible Securities

    The split proportionately adjusted the number of shares issuable upon exercise or vesting of outstanding warrants, restricted stock units, and convertible preferred stock, increasing their exercise or conversion prices.

  • No Change to Authorized Shares

    The total number of authorized shares of common stock or preferred stock was not changed by the reverse split.


Analysis · SHPH · Life Sciences

Shuttle Pharmaceuticals has formally executed a 1-for-10 reverse stock split, a critical step often undertaken by companies facing potential delisting due to low share price. This action, previously approved by shareholders and announced in news, legally alters the company's share structure and is essential for maintaining its Nasdaq listing, especially given its recent history of going concern warnings and lack of revenue.

How filings like this one have moved

In the 30 days to Sep 12, 2026, 29.9% of the 1944 measured filings Wiseek scored 7 moved their stock by 5% or more by the next session's close. The median move was -0.15%. These are measured outcomes after filings of this importance, not a forecast for this one.

Measured one observation per ticker per day, after exclusions. Current figures: Filing Impact Tracker · open dataset

At the time of this filing, SHPH was trading at $4.18 on NASDAQ in the Life Sciences sector. The 52-week trading range was $3.81 to $61.93. This filing was assessed with negative market sentiment and an importance score of 7 out of 10.

View Main SEC Filing

Price Chart

Share this article

Copied!

SHPH - Latest Insights

SHPH
Sep 11, 2026, 7:30 AM EDT
Filing Type: 8-K
Importance Score:
7
Price at Filing: $3.42
Real-time Price: $3.42 info
Change: +$0.0006 (+0.02%) info
Market Cap: $2.249M info
SHPH
Aug 28, 2026, 4:45 PM EDT
Filing Type: 8-K
Importance Score:
9
Price at Filing: $3.54
Real-time Price: $3.42 info
Change: -$0.1194 (-3%) info
Market Cap: $2.249M info
SHPH
Aug 13, 2026, 4:30 PM EDT
Filing Type: DEF 14A
Importance Score:
8
Price at Filing: $4.58
Real-time Price: $3.42 info
Change: -$1.16 (-25%) info
Market Cap: $2.249M info
SHPH
Aug 03, 2026, 5:15 PM EDT
Filing Type: PRE 14A
Importance Score:
9
Price at Filing: $3.39
Real-time Price: $3.42 info
Change: +$0.0265 (+0.78%) info
Market Cap: $2.249M info
SHPH
Jul 13, 2026, 2:34 PM EDT
Filing Type: 4
Importance Score:
7
Price at Filing: $2.99
Real-time Price: $3.42 info
Change: +$0.4306 (+14%) info
Market Cap: $2.249M info